PL3911305T3 - Sposób wytwarzania kompozycji farmaceutycznej zawierającej nefopam i acetaminofen oraz kompozycja farmaceutyczna uzyskana wspomnianym sposobem - Google Patents
Sposób wytwarzania kompozycji farmaceutycznej zawierającej nefopam i acetaminofen oraz kompozycja farmaceutyczna uzyskana wspomnianym sposobemInfo
- Publication number
- PL3911305T3 PL3911305T3 PL20702409.2T PL20702409T PL3911305T3 PL 3911305 T3 PL3911305 T3 PL 3911305T3 PL 20702409 T PL20702409 T PL 20702409T PL 3911305 T3 PL3911305 T3 PL 3911305T3
- Authority
- PL
- Poland
- Prior art keywords
- pharmaceutical composition
- nefopam
- acetaminophen
- manufacturing
- composition obtained
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/5545—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having eight-membered rings not containing additional condensed or non-condensed nitrogen-containing 3-7 membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Pain & Pain Management (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19151603.8A EP3679926A1 (en) | 2019-01-14 | 2019-01-14 | A method of manufacturing a pharmaceutical composition comprising nefopam and acetaminophen, and the pharmaceutical composition obtained thereby |
| PCT/EP2020/050660 WO2020148217A1 (en) | 2019-01-14 | 2020-01-13 | A method of manufacturing a pharmaceutical composition comprising nefopam and acetaminophen, and the pharmaceutical composition obtained thereby |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3911305T3 true PL3911305T3 (pl) | 2023-10-23 |
Family
ID=65023769
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL20702409.2T PL3911305T3 (pl) | 2019-01-14 | 2020-01-13 | Sposób wytwarzania kompozycji farmaceutycznej zawierającej nefopam i acetaminofen oraz kompozycja farmaceutyczna uzyskana wspomnianym sposobem |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20220257611A1 (pl) |
| EP (2) | EP3679926A1 (pl) |
| JP (1) | JP7336528B2 (pl) |
| CN (1) | CN113365611B (pl) |
| AU (1) | AU2020209883A1 (pl) |
| CA (1) | CA3125814A1 (pl) |
| DK (1) | DK3911305T3 (pl) |
| ES (1) | ES2953126T3 (pl) |
| PL (1) | PL3911305T3 (pl) |
| PT (1) | PT3911305T (pl) |
| WO (1) | WO2020148217A1 (pl) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4279069A1 (en) * | 2022-05-20 | 2023-11-22 | APTYS Pharmaceuticals SAS | A pharmaceutical composition for use in preventing and/or reducing hepatotoxicity induced by acetaminophen |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0607085D0 (en) * | 2006-04-07 | 2006-05-17 | Smithkline Beecham Corp | Novel compositions |
| CN102266563A (zh) * | 2011-07-13 | 2011-12-07 | 赵磊 | 一种复方止痛组合物及其制备方法 |
| BR112017022335A2 (pt) * | 2015-04-24 | 2018-07-10 | Gruenenthal Gmbh | combinação de dose fixa inviolável que fornece rápida liberação de dois fármacos a partir de partículas e matriz |
| CN105030765A (zh) * | 2015-07-03 | 2015-11-11 | 沈阳华泰药物研究有限公司 | 一种镇痛药物组合物及其应用 |
| CN108853038A (zh) * | 2018-08-06 | 2018-11-23 | 成都通德药业有限公司 | 一种对乙酰氨基酚片及其制备工艺 |
| EP3679927A1 (en) * | 2019-01-14 | 2020-07-15 | APTYS Pharmaceuticals SAS | A method of manufacturing a pharmaceutical composition comprising nefopam and acetaminophen, and the pharmaceutical composition obtained thereby |
-
2019
- 2019-01-14 EP EP19151603.8A patent/EP3679926A1/en not_active Withdrawn
-
2020
- 2020-01-13 JP JP2021540847A patent/JP7336528B2/ja active Active
- 2020-01-13 EP EP20702409.2A patent/EP3911305B1/en active Active
- 2020-01-13 US US17/422,448 patent/US20220257611A1/en active Pending
- 2020-01-13 DK DK20702409.2T patent/DK3911305T3/da active
- 2020-01-13 PL PL20702409.2T patent/PL3911305T3/pl unknown
- 2020-01-13 AU AU2020209883A patent/AU2020209883A1/en active Pending
- 2020-01-13 CA CA3125814A patent/CA3125814A1/en active Pending
- 2020-01-13 PT PT207024092T patent/PT3911305T/pt unknown
- 2020-01-13 CN CN202080009051.4A patent/CN113365611B/zh active Active
- 2020-01-13 WO PCT/EP2020/050660 patent/WO2020148217A1/en active Search and Examination
- 2020-01-13 ES ES20702409T patent/ES2953126T3/es active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP2022517616A (ja) | 2022-03-09 |
| CA3125814A1 (en) | 2020-07-23 |
| DK3911305T3 (da) | 2023-09-04 |
| BR112021013764A2 (pt) | 2021-09-21 |
| CN113365611A (zh) | 2021-09-07 |
| ES2953126T3 (es) | 2023-11-08 |
| EP3679926A1 (en) | 2020-07-15 |
| US20220257611A1 (en) | 2022-08-18 |
| PT3911305T (pt) | 2023-08-23 |
| EP3911305A1 (en) | 2021-11-24 |
| EP3911305B1 (en) | 2023-06-07 |
| CN113365611B (zh) | 2023-07-25 |
| WO2020148217A1 (en) | 2020-07-23 |
| AU2020209883A1 (en) | 2021-07-29 |
| JP7336528B2 (ja) | 2023-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3835296A4 (en) | KETOAMIDE COMPOUND AND METHOD FOR THE PREPARATION, PHARMACEUTICAL COMPOSITION AND USE THEREOF | |
| SG11202105850YA (en) | Diphenyl-like compound, intermediate thereof, preparation method therefor, pharmaceutical composition thereof and uses thereof | |
| PT3580208T (pt) | Derivados de 2-(3-(1h-benzo[d]imidazol-1-il)propil)piperidin-3-ol e compostos relacionados como inibidores de prs para tratamento de, por exemplo, cancro | |
| EP3466946A4 (en) | THIOPHENE, PROCESS FOR PRODUCING THE SAME, AND CORRESPONDING PHARMACEUTICAL APPLICATION | |
| EP3907293A4 (en) | BIOCHIP AND MANUFACTURING PROCESS AND USE THEREOF | |
| EP3575428A4 (en) | STEEL MATERIAL AND ITS MANUFACTURING PROCESS | |
| EP3580288A4 (en) | COATING COMPOSITION, MANUFACTURING METHOD FOR IT AND USE OF IT | |
| SG11202106988YA (en) | Pseudo-boehmite, manufacturing process and application thereof | |
| EP3412293A4 (en) | INJECTABLE PHARMACEUTICAL COMPOSITION COMPRISING TRABECTEDINE FOR EXTERNAL USE AT THE GASTROINTESTINAL LEVEL, AND METHOD OF MANUFACTURING THE SAME | |
| GB202015988D0 (en) | A method of forming a composition and the composition formed therefrom | |
| IL286073A (en) | Syringe for drug mixing kit, drug mixing kit and method for its manufacture | |
| EP3777862A4 (en) | COMPOSITION OF MELOXICAM, ITS PREPARATION AND PROCESS OF PREPARATION AND USE | |
| GB201809206D0 (en) | Sp3-bonded carbon materials, methods of manufacturing and uses thereof | |
| IL282817A (en) | New material, production method, and its use | |
| PT3911305T (pt) | Um método de fabrico de uma composição farmacêutica compreendendo nefopam e acetaminofeno, e a composição farmacêutica assim obtida | |
| EP3415266A4 (en) | JOINT MASS, METHOD FOR THE PRODUCTION OF JOINT MASS AND METHOD FOR THE PRODUCTION OF A CONNECTING STRUCTURE | |
| EP3813760A4 (en) | MEDICATION CONTAINER, METHOD OF CONTAINER ASSEMBLY AND METHOD OF MAKING THE CONTAINER | |
| KR102380771B9 (ko) | 압전소자 및 압전소자 제조방법 | |
| EP3741364A4 (en) | PHARMACEUTICAL COMPOSITION, PLASTER AND METHOD OF MANUFACTURING THEREOF, ANALGETIC METHOD AND USE | |
| EP3760255A4 (en) | SYRINGE, SYRINGE SET AND SYRINGE MANUFACTURING METHOD | |
| EP3708157A4 (en) | ACETAMINOPHEN PREPARATION AND METHOD FOR MANUFACTURING THEREOF | |
| EP3741427A4 (en) | NEUROSTIMULATOR AND MANUFACTURING METHOD FOR IT | |
| IL286068A (en) | A drug mixing device, a drug mixing kit including the same and a method for its production | |
| IL284132A (en) | A pharmaceutical compound, a method for its preparation and its use as a medicinal substance | |
| EP3831883A4 (en) | COMPOSITE, PROCESS FOR ITS PRODUCTION AND ITS USE |